Merck KGaA to Acquire Bio-Techne for $11.3B, Expanding Life Science Tools Presence (opens in new tab)

The deal would add Bio-Techne’s multiomics offerings, analytical technologies, and integrated workflow solutions to German Merck’s platforms and services in research, bioprocessing and advanced therapeutics, with the aim of creating a combined company capable of helping customers from discovery and translational research through development, testing and commercial manufacturing. The post appeared first on .